Form 4: UnitedHealth Group CFO John F. Rex Reports Stock Transactions
SEC Form 4
John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and non-qualified stock options on February 20 and 21, 2025.
Summary
- John F. Rex, the President & CFO of UnitedHealth Group, filed a Form 4 detailing changes in beneficial ownership.
- On February 20, 2025, Rex acquired 11,763 shares of common stock related to the settlement of Performance Share Awards for the 2022-2024 performance period.
- Also on February 20, 2025, Rex disposed of 5,787.397 shares of common stock at a price of $502.42.
- Rex acquired 7,464 restricted stock units on February 20, 2025, which vest at a rate of 25% annually from 2026 through 2029.
- On February 21, 2025, Rex disposed of 1,078.231, 823.165 and 678.871 shares of common stock at a price of $466.42.
- Rex also acquired 31,657 non-qualified stock options on February 20, 2025, which vest at a rate of 25% annually from 2026 through 2029.
- Following these transactions, Rex directly owns 186,545.044 shares of common stock and indirectly owns 6,791 shares through a trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. While stock disposals can sometimes raise concerns, the acquisitions through performance awards and grants of new equity suggest a continued alignment of interests.
Positives
- The acquisition of shares through Performance Share Awards indicates achievement of performance goals.
- The grant of restricted stock units and non-qualified stock options suggests continued alignment of executive incentives with shareholder value.
Negatives
- The disposal of shares by the CFO could be interpreted negatively by some investors, although it may be part of a pre-planned strategy.
Risks
- Executive stock transactions are always subject to scrutiny and can influence investor sentiment.
- Significant changes in ownership could signal shifts in management's confidence, although this filing appears routine.
Future Outlook
The restricted stock units and non-qualified stock options vest annually from 2026 through 2029, indicating a long-term incentive structure.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, and this filing provides transparency into the holdings of UnitedHealth Group's CFO.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are standard practice among large publicly traded companies like UnitedHealth Group.
- Companies like CVS Health, Anthem (now Elevance Health), and Cigna also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and performance-based awards are generally in line with industry norms for executive compensation.
Stakeholder Impact
- Shareholders may be interested in the details of executive compensation and stock ownership.
- Employees may view the performance share awards as a reflection of company performance.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of common stock acquisition (Performance Share Awards settlement), stock disposal, and grant of restricted stock units and non-qualified stock options. |
| 02/21/2025 | Date of common stock disposal. |
| 02/24/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.